Literature DB >> 24768616

Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging.

Chigumi Ohtsuka1, Makoto Sasaki2, Kanako Konno3, Kanako Kato3, Junko Takahashi3, Fumio Yamashita2, Yasuo Terayama3.   

Abstract

PURPOSE: The purpose of this study was to investigate whether the signal intensity of the substantia nigra pars compacta (SNc) and locus coeruleus (LC) on neuromelanin-sensitive magnetic resonance imaging (MRI) can discriminate early-stage parkinsonism disorders, for which differential diagnosis is generally difficult.
METHODS: Neuromelanin-sensitive MRI at 3 T was performed in 53 patients with early parkinsonism and 22 healthy controls. After an observation period of >1.5 year, the patients were clinically diagnosed with Parkinson's disease (PD; n = 30), multiple system atrophy with predominant parkinsonism (MSA-P; n = 10), or progressive supranuclear palsy syndrome (PSPS; n = 13). The signal intensity of the lateral, central, and medial parts of the SNc and the LC were measured and the contrast ratios (CR) against adjacent white-matter structures was calculated.
RESULTS: The CR of the lateral SNc was lower in the PD and MSA-P groups than in the PSPS and control groups (p = 0.0001-0.05). The CR of the LC was lower in the PD group than in the other groups (p = 0.0001-0.05). Sensitivity and specificity of the CRs for discriminating PD from MSA-P was 60% and 90%, respectively, those for PD/PSPS were 63-88% and 77-92%, respectively, and those for MSA-P/PSPS were 80% and 85%, respectively. These properties were comparable or better to MIBG scintigraphy.
CONCLUSIONS: Neuromelanin-sensitive MRI can depict differences in signal intensity of the lateral SNc and the LC among the parkinsonism disorders at their early stages.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Differential diagnosis; MIBG scintigraphy; Magnetic resonance imaging; Neuromelanin; Parkinson's disease

Mesh:

Substances:

Year:  2014        PMID: 24768616     DOI: 10.1016/j.parkreldis.2014.04.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  38 in total

1.  Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.

Authors:  Keita Kuya; Yuki Shinohara; Fuminori Miyoshi; Shinya Fujii; Yoshio Tanabe; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2016-01-16       Impact factor: 2.804

2.  Signal Alteration of Substantia Nigra on 3.0T Susceptibility-weighted Imaging in Parkinson's Disease and Vascular Parkinsonism.

Authors:  Xue-Jun Zhao; Xi-Yuan Niu; He-Yang You; Min Zhou; Xue-Bing Ji; Ying Liu; Lei Wu; Xiao-Ling Ding
Journal:  Curr Med Sci       Date:  2019-10-14

3.  Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson's disease and factor analysis for its heterogeneity: a systematic review and meta-analysis.

Authors:  Se Jin Cho; Yun Jung Bae; Jong-Min Kim; Donghyun Kim; Sung Hyun Baik; Leonard Sunwoo; Byung Se Choi; Jae Hyoung Kim
Journal:  Eur Radiol       Date:  2020-09-04       Impact factor: 5.315

Review 4.  [Helpful instrumental examinations in idiopathic Parkinson's disease].

Authors:  U Walter; H Zach; I Liepelt-Scarfone; W Maetzler
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

5.  Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.

Authors:  Taku Hatano; Ayami Okuzumi; Koji Kamagata; Kensuke Daida; Daisuke Taniguchi; Masaaki Hori; Hiroyo Yoshino; Shigeki Aoki; Nobutaka Hattori
Journal:  J Neural Transm (Vienna)       Date:  2017-02-03       Impact factor: 3.575

Review 6.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

7.  Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches.

Authors:  Paula Trujillo; Paul E Summers; Alex K Smith; Seth A Smith; Luca T Mainardi; Sergio Cerutti; Daniel O Claassen; Antonella Costa
Journal:  Neuroradiology       Date:  2017-10-06       Impact factor: 2.804

Review 8.  MRI biomarkers of motor and non-motor symptoms in Parkinson's disease.

Authors:  Sephira G Ryman; Kathleen L Poston
Journal:  Parkinsonism Relat Disord       Date:  2019-10-10       Impact factor: 4.891

Review 9.  Role of Magnetic Resonance Imaging in the Diagnosis of Multiple System Atrophy.

Authors:  Han-Joon Kim; Beomseok Jeon; Victor S C Fung
Journal:  Mov Disord Clin Pract       Date:  2016-07-28

Review 10.  Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism.

Authors:  Nicola Pavese; Yen F Tai
Journal:  Mov Disord Clin Pract       Date:  2018-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.